Baird Financial Group, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Baird Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$120.42 - $169.29 $166,059 - $233,450	-1,379 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $23,528 - $32,173	185 Added 15.49%	1,379 $225,000
Q4 2021 Feb 09, 2022	BUY	$159.56 - $209.29 $3,989 - $5,232	25 Added 2.14%	1,194 $202,000
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $198,437 - $242,836	1,169 New	1,169 $221,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.